NeuroPace (NPCE) Cash from Financing Activities (2020 - 2026)
NeuroPace has reported Cash from Financing Activities over the past 7 years, most recently at -$166000.0 for Q1 2026.
- For Q1 2026, Cash from Financing Activities fell 100.79% year-over-year to -$166000.0; the TTM value through Mar 2026 reached -$1.7 million, down 106.6%, while the annual FY2025 figure was $19.6 million, 352.97% up from the prior year.
- Cash from Financing Activities for Q1 2026 was -$166000.0 at NeuroPace, down from $635000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $21.1 million in Q1 2025 and troughed at -$1.9 million in Q2 2025.
- A 5-year average of $1.9 million and a median of $72000.0 in 2024 define the central range for Cash from Financing Activities.
- Biggest five-year swings in Cash from Financing Activities: plummeted 25600.0% in 2023 and later skyrocketed 29216.67% in 2025.
- Year by year, Cash from Financing Activities stood at -$138000.0 in 2022, then skyrocketed by 6052.17% to $8.2 million in 2023, then plummeted by 89.68% to $848000.0 in 2024, then decreased by 25.12% to $635000.0 in 2025, then tumbled by 126.14% to -$166000.0 in 2026.
- Business Quant data shows Cash from Financing Activities for NPCE at -$166000.0 in Q1 2026, $635000.0 in Q4 2025, and -$235000.0 in Q3 2025.